Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Change in Account Payables (2017 - 2020)

enVVeno Medical has reported Change in Account Payables over the past 4 years, most recently at $416133.0 for Q4 2020.

  • Quarterly results put Change in Account Payables at $416133.0 for Q4 2020, up 4119.56% from a year ago — trailing twelve months through Dec 2020 was $169173.0 (up 17.43% YoY), and the annual figure for FY2023 was -$221000.0, down 351.14%.
  • Change in Account Payables for Q4 2020 was $416133.0 at enVVeno Medical, up from -$593127.0 in the prior quarter.
  • Over the last five years, Change in Account Payables for NVNO hit a ceiling of $416133.0 in Q4 2020 and a floor of -$593127.0 in Q3 2020.
  • Median Change in Account Payables over the past 4 years was $16589.0 (2019), compared with a mean of $22509.3.
  • Peak annual rise in Change in Account Payables hit 4119.56% in 2020, while the deepest fall reached 4209.24% in 2020.
  • enVVeno Medical's Change in Account Payables stood at $321010.0 in 2017, then crashed by 145.33% to -$145504.0 in 2018, then surged by 106.78% to $9862.0 in 2019, then surged by 4119.56% to $416133.0 in 2020.
  • The last three reported values for Change in Account Payables were $416133.0 (Q4 2020), -$593127.0 (Q3 2020), and $169550.0 (Q2 2020) per Business Quant data.